PHILADELPHIA — Multiple, evidence-based strategies can decrease CV events in high-risk people with diabetes, yet clinicians must individualize approaches based on patient preference, individual risk factors and cost, according to a speaker.
“Many amazing therapies dramatically improve outcomes,” Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC, director of the lipid clinic, associate director of the clinical nutrition and risk factor modification center, and associate scientist in the Li Ka Shing Knowledge Institute at St. Michael’s Hospital in Toronto, said during